Archive: 10/12/2012

FDA OKs expanded use of prostate cancer drug

(HealthDay)—The approved use of the drug Zytiga has been expanded to include treatment of men with late-stage, hormone therapy-resistant prostate cancer before they undergo chemotherapy, the U.S. Food and Drug Administration ...

Dec 10, 2012
popularity1 comments 0

Gene-environment interaction ups risk of preeclampsia

(HealthDay)—A genetic variant, AGT2R, in mothers, fathers, and neonates is associated with a significantly increased risk of preeclampsia in mothers with a body mass index (BMI) of 25 kg/m² or more, according to a study ...

Dec 10, 2012
popularity0 comments 0